After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Catalyst Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Catalyst Pharmaceuticals Inc is $2.75B. A total of 0.85 million shares were traded on the day, compared to an average of 1.15M shares.
In the most recent transaction, Miller Steve sold 50,000 shares of CPRX for 21.93 per share on Dec 10 ’24. After the transaction, the Chief Op. & Scientific Officer now owns 686,996 company shares. In a previous transaction on Dec 10 ’24, Miller Steve bought 50,000 shares at 21.93 per share.
Among the insiders who sold shares, INGENITO GARY disposed of 12,000 shares on Nov 27 ’24 at a per-share price of $22.72. This resulted in the Chief Med. & Reg. Officer holding 51,391 shares of CPRX after the transaction. In another insider transaction, Harper Molly sold 17,500 shares at $22.00 per share on Nov 27 ’24. Company shares held by the Director now total 0.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CPRX has a high of $24.64 and a low of $13.12.
As of this writing, CPRX has an earnings estimate of $0.55 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $0.59 per share and a lower estimate of $0.52.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CPRX’s latest balance sheet shows that the firm has $191.27M in Cash & Short Term Investments as of fiscal 2021. There were $4.20M in debt and $27.06M in liabilities at the time. Its Book Value Per Share was $5.54, while its Total Shareholder’s Equity was $206.83M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CPRX is Buy with a score of 5.00.
